White House withdraws nomination of Heidi Overton to lead FDA
Key Points:
- The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration amid bipartisan Senate concerns about her loyalty to Trump and stance on vaccines.
- Overton, a physician and vocal abortion opponent with ties to Trump and conservative groups, faced scrutiny over her support for breaking up combination vaccines and her willingness to challenge Trump’s vaccine misinformation.
- Republican Senator Bill Cassidy, chair of the Senate health committee, remained undecided on Overton and previously criticized her views as "almost disqualifying."
- Reproductive rights advocates praised the withdrawal, citing Overton’s opposition to medication abortion access and warning of continued resistance to similar nominees.
- Overton’s confirmation was unlikely without full Republican committee support, and Republicans are rushing to confirm Trump nominees before Senate control shifts to Democrats in January.